Picafibrate is a fibrate class medication primarily indicated for the treatment of hyperlipidemia by effectively lowering triglyceride and LDL cholesterol levels in the bloodstream. As a peroxisome proliferator-activated… Read more
Picafibrate is a fibrate class medication primarily indicated for the treatment of hyperlipidemia by effectively lowering triglyceride and LDL cholesterol levels in the bloodstream. As a peroxisome proliferator-activated receptor alpha agonist, this compound functions by increasing lipoprotein lipase activity to manage lipid profiles. This category contains high-quality reference standards for picafibrate, including its known pharmaceutical impurities, metabolites, and stable isotope labelled compounds. These materials are essential for rigorous analytical testing, enabling laboratories to perform accurate impurity profiling and method validation throughout the drug development lifecycle. By utilizing these precise reference materials, researchers and quality control scientists can ensure compliance with regulatory standards, verify the identity and purity of active pharmaceutical ingredients, and reliably quantify analytes in complex biological matrices or stability studies.